[Federal Register Volume 85, Number 248 (Monday, December 28, 2020)]
[Notices]
[Page 84358]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28529]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The cooperative agreement applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the cooperative agreement 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel CTSA Review.
    Date: January 29, 2021.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Center for Advancing Translational Sciences; 
National Institutes of Health, 6701 Democracy Boulevard, Room 1080, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Victor Henriquez, Ph.D., Scientific Review 
Officer, Office of Scientific Director, National Center for 
Advancing Translational Sciences, National Institutes of Health, 
6701 Democracy Boulevard, Room 1080, Bethesda, MD 20892-4878, 301-
435-0813, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: December 18, 2020.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-28529 Filed 12-23-20; 8:45 am]
BILLING CODE 4140-01-P